Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2003

View Archived Issues

SYM-2081 attenuates inflammatory hyperalgesia

KRN-5500 shows significant activity against CLL cells in vitro

VEGF Trap prevents blinding blood vessel growth in mice

Ghrelin could have therapeutic value in endotoxic shock

Reductions in NK-kappaB activation may improve the outcome for sepsis

Sepracor reports phase III Estorra data in elderly patients

Enbrel approved for inhibition of bone and joint damage in psoriatic arthritis patients

Estrogen receptor agonist as a potential new treatment for hot flush

Oxymorphazole: a potent antinociceptive agent in mice

LY-503430: a new neuroprotective agent with therapeutic potential in Parkinson's disease

Two series of rifamycin antibiotics patented by ActivBiotics scientists

Novel imaging agents for the diagnosis of AD developed at Amersham

New anti-herpesvirus DNA polymerase agents identified at Pharmacia

Guilford presents new DPP-IV inhibitors for Parkinson's disease and other neurological disorders

South African approval to begin phase I trial of HIVA.MVA

Phase IIa DB-289 malaria study completes first stage

EpiPen approved in Japan for anaphylaxis triggered by insect stings

Long-lasting tumor responses seen in phase II NHL study of pixantrone

NIH program to evaluate Maxheal for SARS

Health Canada accepts Bexxar under priority review

APF-112 set to enter phase II postsurgical pain relief study in September

RealArt HPA Coronavirus test CE marked

Leptin exerts cardiac antihypertrophic effects in mice independent of weight loss

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...